Rodgers Richard J

CIK 00013133977 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001313397

Recent Transactions

50 trades

Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2025-10-29+3,800→ 28,490 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2025-10-29−3,800→ 0 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2025-06-20+18,884→ 18,884 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2025-06-20$6.42/sh+28,326→ 28,326 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+41,551→ 413,543 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+21,468→ 371,992 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-06-18+54,059→ 54,059 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2025-06-12−10,420→ 0 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2025-06-12+10,420→ 24,690 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2025-04-30+79,504→ 318,655 total
Award
Opus Genetics, Inc.$IRD
Stock Option (Right to Buy)
2025-04-30+79,592→ 79,592 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2025-01-16$0.55/sh+100,000→ 350,524 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-01-16−100,000→ 0 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-10-29+3,800→ 14,270 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-10-29−3,800→ 3,800 total
Award
ARDELYX, INC.$ARDX
Common Stock
2024-06-14+12,204→ 250,524 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2024-06-14+40,243→ 40,243 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-06-12−6,670→ 0 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-06-12+6,670→ 10,470 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2024-06-12+10,420→ 10,420 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2024-06-12$15.86/sh+15,630→ 15,630 total
Award
Opus Genetics, Inc.$IRD
Stock Option (Right to Buy)
2024-06-11+35,181→ 35,181 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2024-06-11+41,143→ 239,151 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2024-01-01+24,762→ 198,008 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2023-11-01+35,000→ 173,246 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2023-10-29−3,800→ 7,600 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2023-10-29+3,800→ 3,800 total
Disposition to Issuer
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18−1,976→ 0 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18+1,976→ 1,976 total
Disposition to Issuer
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18−23,216→ 0 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18+23,216→ 23,216 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18+23,839→ 23,839 total
Disposition to Issuer
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2023-07-18−23,839→ 0 total
Award
ARDELYX, INC.$ARDX
Common Stock
2023-06-15+18,494→ 238,320 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2023-06-15+49,237→ 49,237 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2023-06-12+6,670→ 6,670 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2023-06-12+7,710→ 7,710 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2023-04-19+50,000→ 138,246 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2023-01-11+20,822→ 88,246 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to buy)
2022-10-29+17,095→ 17,095 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2022-10-29+11,400→ 11,400 total
Exercise of In-Money
Opus Genetics, Inc.$IRD
Series B Warrant (right to buy)
2022-10-03−3,148→ 0 total
Exercise of In-Money
Opus Genetics, Inc.$IRD
Common Stock
2022-10-03$0.00/sh+3,148→ 67,424 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2022-07-01+7,812→ 48,435 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2022-07-01+15,841→ 64,276 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2022-06-15+100,000→ 100,000 total
Award
ARDELYX, INC.$ARDX
Common Stock
2022-06-15+132,299→ 219,826 total
Award
Opus Genetics, Inc.$IRD
Stock Option (right to buy)
2022-06-13+20,000→ 20,000 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2022-04-01+4,629→ 40,623 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2022-01-03+4,021→ 35,994 total

Companies

Recent Filings

Address

C/O ABRAXIS BIOSCIENCE, INC. 11755 WILSHIRE BLVD., 20TH FLOOR

LOS ANGELES, CA, 90025

View on SEC.gov